Home/Filings/5/0001181431-10-009455
5//SEC Filing

Wallroth Donald E. 5

Accession 0001181431-10-009455

CIK 0001340752other

Filed

Feb 15, 7:00 PM ET

Accepted

Feb 16, 9:39 PM ET

Size

25.9 KB

Accession

0001181431-10-009455

Insider Transaction Report

Form 5
Period: 2009-12-31
Wallroth Donald E.
Chief Financial Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2009-09-25$3.93/sh+4,000$15,72024,000 total
  • Exercise/Conversion

    Common Stock

    2009-09-22$3.93/sh+4,000$15,72012,000 total
  • Exercise/Conversion

    Common Stock

    2009-09-24$3.93/sh+4,000$15,72020,000 total
  • Exercise/Conversion

    Common Stock

    2009-09-28$3.93/sh+13,500$53,05537,500 total
  • Disposition to Issuer

    Common Stock

    2009-08-2213,5000 total
  • Exercise/Conversion

    Common Stock

    2009-09-18$3.93/sh+8,000$31,4408,000 total
  • Exercise/Conversion

    Common Stock

    2009-09-23$3.93/sh+4,000$15,72016,000 total
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2009-09-254,0000 total
    Exercise: $3.93From: 2009-08-22Exp: 2010-11-22Common Stock (4,000 underlying)
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2009-09-2813,5000 total
    Exercise: $3.93From: 2009-08-22Exp: 2010-11-22Common Stock (13,500 underlying)
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2009-09-188,0000 total
    Exercise: $3.93From: 2009-08-22Exp: 2010-11-22Common Stock (8,000 underlying)
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2009-09-224,0000 total
    Exercise: $3.93From: 2009-08-22Exp: 2010-11-22Common Stock (4,000 underlying)
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2009-09-234,0000 total
    Exercise: $3.93From: 2009-08-22Exp: 2010-11-22Common Stock (4,000 underlying)
  • Exercise/Conversion

    Employee Stock Option (right to buy)

    2009-09-244,0000 total
    Exercise: $3.93From: 2009-08-22Exp: 2010-11-22Common Stock (4,000 underlying)
Footnotes (1)
  • [F1]This is a portion of the option that was granted on May 12, 2009. The vesting was accelerated on August 22, 2009, with an exercise period till November 22, 2010.

Issuer

Molecular Insight Pharmaceuticals, Inc.

CIK 0001340752

Entity typeother

Related Parties

1
  • filerCIK 0001410709

Filing Metadata

Form type
5
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 9:39 PM ET
Size
25.9 KB